Insufficient scRNA-seq data for expression of TMEM161A at single-cell level.
Insufficient scRNA-seq data for expression of TMEM161A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1486.93 | 1445 / 1445 | 100% | 29.17 | 183 / 183 |
liver | 100% | 1686.01 | 226 / 226 | 100% | 46.32 | 406 / 406 |
ovary | 100% | 1970.94 | 180 / 180 | 100% | 44.27 | 430 / 430 |
pancreas | 100% | 1027.41 | 328 / 328 | 100% | 27.33 | 178 / 178 |
uterus | 100% | 2398.17 | 170 / 170 | 100% | 42.24 | 458 / 459 |
thymus | 100% | 2621.58 | 653 / 653 | 100% | 37.76 | 602 / 605 |
stomach | 100% | 1341.73 | 359 / 359 | 99% | 40.23 | 284 / 286 |
intestine | 100% | 1588.49 | 966 / 966 | 99% | 45.83 | 523 / 527 |
kidney | 100% | 1661.09 | 89 / 89 | 99% | 30.81 | 894 / 901 |
brain | 99% | 938.83 | 2621 / 2642 | 100% | 32.34 | 705 / 705 |
prostate | 100% | 1963.45 | 245 / 245 | 99% | 53.94 | 498 / 502 |
skin | 100% | 1639.85 | 1809 / 1809 | 99% | 42.21 | 468 / 472 |
bladder | 100% | 1535.95 | 21 / 21 | 99% | 42.71 | 499 / 504 |
adrenal gland | 100% | 2370.86 | 258 / 258 | 99% | 34.61 | 227 / 230 |
breast | 100% | 1489.46 | 459 / 459 | 99% | 32.09 | 1102 / 1118 |
lung | 100% | 1354.94 | 577 / 578 | 98% | 34.28 | 1134 / 1155 |
adipose | 100% | 1302.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 59.34 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.87 | 29 / 29 |
muscle | 100% | 2606.49 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1509.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 44.17 | 1 / 1 |
blood vessel | 100% | 1195.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1203.05 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 641.33 | 725 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032526 | Biological process | response to retinoic acid |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_1902230 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0034644 | Biological process | cellular response to UV |
GO_0045739 | Biological process | positive regulation of DNA repair |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | TMEM161A |
Protein name | Transmembrane protein 161A Transmembrane protein 161A (Adaptive response to oxidative stress protein 29) (AROS-29) |
Synonyms | UNQ582/PRO1152 |
Description | FUNCTION: May play a role in protection against oxidative stress. Overexpression leads to reduced levels of oxidant-induced DNA damage and apoptosis. . |
Accessions | ENST00000587915.1 V9GYP8 K7EKY7 ENST00000587096.5 K7EQ34 K7EPA3 ENST00000592369.1 U3KQT6 ENST00000587925.5 K7EQE7 ENST00000587583.6 ENST00000590216.6 Q9NX61 ENST00000162044.14 [Q9NX61-1] ENST00000587985.6 K7EJK6 ENST00000450333.6 [Q9NX61-2] |